Download Citation
Article Source:
A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia
Schweighofer CD,
Coombes KR,
Barron LL,
Diao L,
Newman RJ,
et al.
(2011)
A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia.
PLOS ONE 6(12): e28277.
https://doi.org/10.1371/journal.pone.0028277